University Hospital Frankfurt, Goethe-University Frankfurt/Main, Department of General and Visceral Surgery, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany.
University Hospital Frankfurt, Goethe-University Frankfurt/Main, Department of General and Visceral Surgery, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany.
J Geriatr Oncol. 2018 Nov;9(6):649-658. doi: 10.1016/j.jgo.2018.05.001. Epub 2018 May 18.
The aim of this study is to investigate the effect of age on patient outcome after colorectal carcinoma (CRC) resection in patients over 65 years of age.
This study included patients aged 65 years and older who underwent CRC resection between 2003 and 2013 at a single-center institution. Patients were divided into two groups: Group A (65-74 years old) and Group B (≥75 years old).
Multivariable logistic analysis of 415 patients revealed serum albumin levels on the third postoperative day (POD) (Odds Ratio (OR), 0.44; 95% CI, 0.21-0.94; P = 0.03) and C-reactive protein (CRP) levels (OR, 1.05; 95% CI, 1.00-1.01; P = 0.04) in patients with colon cancer as predictive factors for morbidity. In addition, the multivariable logistic analysis revealed serum albumin levels (OR, 0.27; 95% CI, 0.08-0.87; P = 0.03) in patients with rectal cancer as predictive factors for morbidity. The multivariate Cox Proportional Hazards Model identified re-intervention for colon cancer (Hazard Ratio (HR), 4.57; 95% CI, 1.36-15.4 P = 0.01) and for rectal cancer (HR, 11.8; 95% CI, 1.08-129 P = 0.04) as a predictive factor for 30-day mortality. Serum albumin level on the third POD was predictive of 30-day mortality (HR, 0.30; 95% CI, 0.13-0.71; P = 0.01) and of 1-year mortality (HR, 0.34; 95% CI, 0.17-0.66; P < 0.01) in patients with colon cancer.
Age is not predictive of postoperative morbidity and mortality in patients with CRC. Serum albumin levels on the third POD can predict morbidity and mortality for colon and rectal carcinoma in older patients undergoing colorectal resections.
本研究旨在探讨年龄对 65 岁以上结直肠癌(CRC)患者手术后患者结局的影响。
本研究纳入了 2003 年至 2013 年在单中心机构接受 CRC 切除术的年龄在 65 岁及以上的患者。患者分为两组:A 组(65-74 岁)和 B 组(≥75 岁)。
对 415 例患者的多变量逻辑分析显示,结肠癌患者术后第 3 天(POD)的血清白蛋白水平(优势比(OR),0.44;95%CI,0.21-0.94;P=0.03)和 C 反应蛋白(CRP)水平(OR,1.05;95%CI,1.00-1.01;P=0.04)是发病率的预测因素。此外,多变量逻辑分析显示,直肠癌患者的血清白蛋白水平(OR,0.27;95%CI,0.08-0.87;P=0.03)是发病率的预测因素。多变量 Cox 比例风险模型确定结肠癌的再次干预(危险比(HR),4.57;95%CI,1.36-15.4;P=0.01)和直肠癌(HR,11.8;95%CI,1.08-129;P=0.04)是 30 天死亡率的预测因素。第 3 POD 的血清白蛋白水平预测 30 天死亡率(HR,0.30;95%CI,0.13-0.71;P=0.01)和结肠癌患者 1 年死亡率(HR,0.34;95%CI,0.17-0.66;P<0.01)。
年龄不能预测 CRC 患者术后发病率和死亡率。第 3 POD 的血清白蛋白水平可预测行结直肠切除术的老年结肠癌和直肠癌患者的发病率和死亡率。